The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervix
- PMID: 20199664
- PMCID: PMC2852389
- DOI: 10.1186/1756-0500-3-54
The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervix
Abstract
Background: The origin of adenocarcinomas presenting on the cervix uteri may be doubtful, i.e. whether it is of cervical or endometrial origin, due to the overlapping morphological features. In HPV negative samples, further tests may be needed to ascertain the nature of the tumours. We aimed to explore the use of immunohistochemistry profiles in tissue microarrays in archived samples of adenocarcinoma (ADC) of the cervix from Uganda that tested negative for HPV DNA.
Findings: Five commercially available antibodies were tested in tissue array sections immunostained utilizing the avidin-biotin (AB) technique. In 26 ADC samples, HPV was detected in 13, p16 in 15 (8 in HPV positive and 7 in HPV negative), CEA in 12, vimentin in 6, ER in 0, and PR in 2. Among the 13/25 HPV negative ADC samples, five were positive for CEA suggesting endocervical origin, and three were vimentin positive (one had a mucinous endocervical histological pattern and two were ADC, not otherwise specified, most likely of endometrial origin).
Conclusions: The immunoprofiles of ADC with the antibodies studied are rather nonspecific. By using immunohistochemistry in 13 HPV negative ADC, endocervical tumour origin was suspected in five CEA positive cases while two out of three vimentin positive samples were probably of endometrial origin, suggesting that CEA and vimentin may be valuable in distinguishing HPV negative cervical adenocarcinomas from endometrial adenocarcinomas.
Figures
Similar articles
-
Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.Virchows Arch. 2003 Mar;442(3):271-7. doi: 10.1007/s00428-002-0752-4. Epub 2003 Feb 12. Virchows Arch. 2003. PMID: 12647218
-
Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?Virchows Arch. 2010 Apr;456(4):377-86. doi: 10.1007/s00428-010-0892-x. Epub 2010 Mar 11. Virchows Arch. 2010. PMID: 20221633
-
A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.Am J Surg Pathol. 2010 Jul;34(7):915-26. doi: 10.1097/PAS.0b013e3181e3291e. Am J Surg Pathol. 2010. PMID: 20534993 Free PMC article.
-
p16 expression in the female genital tract and its value in diagnosis.Adv Anat Pathol. 2006 Jan;13(1):8-15. doi: 10.1097/01.pap.0000201828.92719.f3. Adv Anat Pathol. 2006. PMID: 16462152 Review.
-
Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.Histopathology. 2020 Jan;76(1):112-127. doi: 10.1111/his.13995. Histopathology. 2020. PMID: 31846527 Review.
Cited by
-
[Diagnosis and differential diagnosis of cervical adenocarcinoma].Pathologe. 2011 Nov;32(6):505-13. doi: 10.1007/s00292-011-1481-8. Pathologe. 2011. PMID: 22038135 Review. German.
References
-
- Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F. - DOI - PubMed
-
- Bosch FX, de Sanjose S. Human papillomavirus and cervical cancer--burden and assessment of causality. J Natl Cancer Inst Monogr. 2003;31:3–13. - PubMed
-
- Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006;98:303–315. - PubMed
-
- Reid-Nicholson M, Iyengar P, Hummer AJ, Linkov I, Asher M, Soslow RA. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. Mod Pathol. 2006;19(8):1091–1100. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials